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Abstract 27 
Background: 28 
The aetiology of bone marrow oedema-like abnormalities (BMOA) seen on magnetic 29 
resonance imaging (MRI) is as yet not fully understood. The current study aimed to 30 
investigate the potential of projection radiography and Raman microspectroscopy to 31 
provide information regarding the underlying physiological changes associated with 32 
BMOA in equine bone samples.  33 
Methods: 34 
MRI was used to assess 65 limbs from 43 horses. A subset of 13 limbs provided 25 35 
samples, 8 with BMOA present and 17 as controls; these were examined with projection 36 
radiography to assess bone mineral density and Raman spectroscopy to assess bone 37 
composition. Statistical analysis was conducted using SPSS, the relationship between 38 
BMOA and age was tested using binary logistic regression, other outcome measures via 39 
unpaired t-tests.  40 
Results: 41 
Overall BMOA was found to be associated with locally increased bone density (p = 42 
0.011), suggesting increased bone formation; however, no measurable changes relating 43 
to bone remodelling were found, and there were no detectable changes in the chemical 44 
composition of bone.  45 
Conclusions: 46 
BMOA is associated with locally increased bone density, without an associated change 47 
in the chemical composition of bone, suggesting this is not linked to BMOA. The 48 
presence of increased bone density associated with BMOA does appear to suggest that 49 
an increased amount of bone formation is occurring in these regions, but as Raman 50 
microspectroscopy data do not demonstrate any significant changes in bone chemical 51 
composition associated with BMOA, it would appear that the increased bone volume is 52 
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due to a greater amount of bone being formed rather than an imbalance in relation to 53 
bone remodelling. 54 
The study provides a proof of principle for the use of Raman microspectroscopy and 55 
projection radiography in in vitro studies of BMOA.  56 
 57 
Keywords 58 
Magnetic resonance imaging 59 
Osteoarthritis 60 
Bone remodelling 61 
Raman 62 
Bone density 63 
Bone marrow oedema 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
 76 
 77 
 78 
4 
 
BACKGROUND 79 
Bone marrow oedema-like lesions seen on magnetic resonance imaging (MRI) tend to 80 
be clinically non-specific in appearance, and thus it is suggested such lesions be 81 
referred to as a bone marrow oedema-like abnormality (BMOA) (1). Excluding those 82 
related to trauma (2),  BMOAs in humans are associated with a range of conditions 83 
including diabetic neuropathy (3), osteoarthritis, rheumatoid arthritis (1), (4) and 84 
osteomyelitis (3).  85 
 86 
As yet, the aetiology of non-acute trauma BMOA within bone is not fully understood. 87 
BMOA has been associated with pain, even in the absence of direct, acute trauma (1) 88 
(5), although BMOA has also been found in both asymptomatic individuals (6) and 89 
asymptomatic athletes (7).  It has been demonstrated that oedema-like appearances 90 
occur when sedentary individuals start a running regime, (5, 6) and these appearances 91 
are generally more common in runners than non-runners (7). In these cases, it has been 92 
suggested that the BMOA patterns might represent the early stages of a stress fracture 93 
(8), in which case the distinction between BMOA (non-traumatic) and bone-bruising 94 
(traumatic) may be less distinct. BMOA has also been described in association with a 95 
transient form of osteoporosis, generally affecting a single bone and concluding with 96 
restoration of the bone mineral density (9). 97 
 98 
Although the clinical significance of BMOA remains unclear, it is nevertheless becoming 99 
increasingly pertinent in the investigation of osteoarthritis. It has been shown that, for 100 
individuals with osteoarthritis of the knee, the majority of subchondral cysts develop from 101 
within regions of bone marrow with oedema-like MRI signal (4, 10) whose presence also 102 
relate to the severity of symptoms,  degree of cartilage degeneration and disease 103 
progression (11-13). Similarly, the Multicentre Osteoarthritis Study (MOST) study 104 
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demonstrated that subchondral BMOA lesions are highly associated with, and predictive 105 
of, bone attrition in individuals who subsequently develop osteoarthritis (14).   106 
 107 
Thus, although BMOA is increasingly being regarded as an important aid for the 108 
differential diagnosis and subsequent disease management of osteoarthritis (10), (14-109 
16), further research is required to investigate the underlying relationship between 110 
BMOA and the physiological changes which underpin the MR image appearance. 111 
Previous studies have shown a range of features associated with the presence of 112 
BMOAs including bone marrow necrosis, bone marrow fibrosis, reduced mineral density 113 
(1, 4) and altered trabecular morphometry (17). Following on from these studies, the aim 114 
of the current study was to investigate BMOA in a range of equine samples measuring 115 
bone density via projection radiography and the chemical composition of bone by 116 
Raman microspectroscopy. 117 
 118 
METHODS 119 
Study Samples 120 
Bone samples were obtained from a local abattoir, where all horses were being 121 
euthanized for humane reasons. Sixty-five samples (some from a single forelimb, some 122 
from both forelimbs, dependent on availability), were collected from 43 horses, the 123 
working histories of which were not known, although observation of the animals prior to 124 
euthanasia indicated a mixed pedigree; yearlings, riding school horses and ponies, as 125 
well as wild Dartmoor ponies. Wherever possible (n = 34), the animals were aged by 126 
experienced abattoir staff (age: mean ± s.d.: 13.4 ± 5.4 years); this provides an 127 
estimation of age, although it is not an entirely precise method (18). The samples 128 
obtained were of the distal third metacarpal bone of the equine forelimb (Figure 1), with 129 
a high-load, high-velocity joint, comprising an articulation between the distal end of the 130 
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third metacarpal bone, the proximal phalanx, and a further articulation between the 131 
palmar surface of the metacarpal and the two proximal sesamoid bones.  132 
 133 
MRI Imaging 134 
MRI imaging was undertaken on fresh, refrigerated, limbs between 4 – 6 hours after the 135 
samples were obtained. The imaging was undertaken using a Philips Intera 1.5 T 136 
scanner (Philips, NV) and a two-element small flex coil. Scans obtained consisted of 137 
short tau inversion recovery (STIR) sequences (repetition time TR 4475 ms, echo time 138 
TE 9 ms, inversion delay TI 150 ms, slice thickness 3 mm, acquired resolution 0.59 × 139 
0.85 mm), T1 weighted sequences (TR 35 ms, TE 5 ms, slice thickness 2 mm, acquired 140 
resolution 0.59 × 0.76 mm) (Figure 2) and T2 weighted sequences (TR 4220 ms, TE 95 141 
ms, slice thickness 3 mm, acquired resolution 0.49 × 0 .62 mm). All scans were obtained 142 
in the sagittal plane, aligned with and parallel to the median sagittal ridge of the distal 143 
third metacarpal bone. In addition, coronal STIR images were occasionally taken to aid 144 
the localisation of specific bone marrow oedema lesions (Figure 3). 145 
 146 
Image evaluation was undertaken by a single, experienced MRI radiographer (author 147 
CJH) who also performed the image acquisition. BMOA was defined as a region of high 148 
signal (hyperintensity) on STIR images and corresponding low signal (hypointensity) on 149 
T1 weighted images [17] (Figure 4) due to oedema or interstitial fluid within the 150 
extracellular spaces of the bone marrow (19). T1 and T2 sequences also allowed the 151 
identification of acute trauma from features such as fracture lines, soft-tissue oedema, 152 
swelling or haemorrhage as well as demonstrable pathology such as limb deformity or 153 
advanced osteoarthritis that would mean samples would be excluded from the study. As 154 
a result, three samples were excluded as the BMOA detected was felt to be due to acute 155 
trauma (the location of the altered signal intensity being suggestive of extreme extension 156 
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of the joint), a blood vessel and a cyst, respectively. The sample with the cyst was 157 
excluded as it may have been representative of advanced osteoarthritis or been a 158 
unicameral or aneurysmal cyst and may have confounded the analysis. The 65 limbs 159 
were then divided chronologically into subsets for pilot and other studies. Thirteen limbs 160 
were selected for subsequent analysis within the present study. Each limb provided two 161 
sample slices (medial and lateral – see below), 8 with BMOA present (mean age ± sd 162 
16.0 ± 4.1 years ) and 17 controls (mean age ± sd 17.2 ± 4.1 years). One sample slice 163 
was excluded due to the presence of a cyst (see above). Of the 8 slices with BMOA 164 
present, six were obtained from limbs with both medial and lateral BMOA, and two from 165 
limbs with medial BMOA only. These 25 sample slices were subsequently investigated 166 
by Raman spectroscopy and projection radiography.  167 
 168 
Raman Microspectroscopy 169 
Raman microspectroscopy was performed on a subset of animals, after pilot studies to 170 
ensure adequate sample preparation. Following MRI scanning and the identification of 171 
areas of BMOA, the distal portion of the third metacarpal bone was dissected. Soft 172 
tissues and ligaments were removed (Figure 5) and two 1 mm slices through the bone 173 
were cut along the sagittal plane, on either side of the midline, passing through the mid-174 
region of the BMOA lesion (when present) or in a corresponding location (typically 10 175 
mm from the midline) when BMOA was not present. The majority of BMOA lesions, and 176 
all eight BMOA lesions in the selected subset (see below), were found in the palmar 177 
condyles, the region of greatest loading in the metacarpal (20) and hence all control 178 
bone sections were taken from the same site. 179 
 180 
Bone slices were fixed in 10% weight by volume (w/v) formalin for 24 hours, rinsed 181 
thoroughly in 0.9% w/v saline, and stored under 0.9% w/v saline. Raman 182 
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microspectroscopy was undertaken within a week of sample preparation, typically within 183 
24 hours. Prior to undertaking Raman microspectroscopy, the surface of each slice of 184 
fixed bone was polished with glass paper (firstly 800 grade, then 1200 grade) to ensure 185 
a uniform, smooth surface, and then cleaned ultrasonically in a 0.9% w/v saline bath for 186 
30 – 60 seconds using a Sonic3000SS Professional (UK) ultrasonic cleaner. This 187 
procedure ensured a smooth, debris-free surface, thereby maximising the amount of 188 
scattered light received by the Raman microscope and thus optimising the quality of the 189 
Raman spectrum generated (21). 190 
  191 
Raman microspectroscopy was undertaken using a Renishaw 1000 Raman Microscope 192 
system (Renishaw, UK), utilising excitation from a 100 mW helium-neon laser, at a 193 
wavelength of 785 nm. Prior to each data collection session the Raman microscope was 194 
calibrated using a wafer of silicon (expected wave number of 520 cm-1). For the 195 
measurements of bone slices, a ×40 microscope objective was used, yielding a field size 196 
in-plane of around 10 µm × 10 µm. Measurements of each sample were obtained at 197 
multiple individual points to provide average data which were unaffected by any local 198 
variations within the bone. Between measurements the sample was moved 199 
approximately 3 mm using a micrometer stage in either the x or y direction such that 200 
sampling had an approximate grid pattern (see Figure 5a for schematic representation of 201 
sampling strategy). The spacing between measurements was not exactly 3 mm because 202 
the sample position was adjusted on the sub-millimetre scale to ensure the laser was 203 
focused on the extracellular matrix (that is mineralised bone). At each location there 204 
were two 10-second data acquisitions. The spectra obtained covered a range of Raman 205 
shifts (Δώ) from 500 cm-1 to 3000 cm-1.  206 
 207 
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Following acquisition, the spectra acquired at each individual location were pre-208 
processed and analysed; a representative spectrum is provided in Figure 6. Initially, 209 
baseline correction was undertaken using the software package provided as part of the 210 
Renishaw system (WiRE 2.0). The areas under the peaks described in Table 1 were 211 
subsequently determined using the curve fitting function provided within the Renishaw 212 
software.  213 
 214 
Table 1: Peaks quantified within Raman spectra. 215 
Chemical Bond / 
Molecule 
Approximate  
Peak Centre (cm-1) 
Range to which peak area 
was fitted (cm-1) 
Proline 855  830 to 870  
Phosphate 
(ν1-phosphate band) 
956  925 to 980  
Phenylalanine 1003  990 to 1010  
Carbonate 
(ν1-carbonate mode) 
1071  1050 to 1095  
Amide III 1240, 1270  1200 to 1300  
Amide I 1665  1565 to 1720  
 216 
Previous studies in bone have demonstrated that Raman microspectroscopy can 217 
determine the changes in bone chemical composition that occur with fracture healing 218 
(22), with aging (23) and with osteoporosis (24). However, it has also been shown that 219 
fixation may lead to alterations in specific peaks within the Raman spectra (25). In the 220 
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present study following peak quantification a range of measures was determined, as 221 
follows:  222 
1) Peak centre value of phosphate to examine crystallinity (26)  223 
2) For an indication of the mineral:matrix  ratio, the ratio of peak areas for 224 
phosphate:amide I and carbonate:amide I (26, 27).   225 
3) The ratio of carbonate:phosphate to examine type B carbonate substitution (27). 226 
 227 
Following analysis of the individual-location spectra, data were averaged over specific 228 
regions of interest within the sample slices. Location names are given such that anterior 229 
would correlate to the dorsal location in the horse, posterior to palmar, upper to proximal 230 
and lower to distal anatomical locations. The sample locations were identified as the 231 
anterior, the posterior upper quadrant (PUQ) and posterior lower quadrant (PLQ), as 232 
shown in Figure 5. The lesion, when present, was within the PLQ, and the area of the 233 
PLQ was defined such that it encompassed all of the lesion with a border in the order of 234 
2 – 3 mm. A within slice ratio (WSR) was subsequently calculated for each of the 235 
parameters, i.e., the ratio of the average value in the PLQ region to the average found in 236 
the anterior and PUQ regions. This was in order to reduce the influence of the 237 
heterogeneity of the sample group: variations of bone composition between animals due 238 
to factors such as age, working history and breed, effectively normalising the PLQ region 239 
to the non-lesion area of bone for each animal. 240 
 241 
Bone Density Measurements. 242 
Following Raman microspectroscopy, projection radiographs were taken of the same 243 
subset of bone slices using a Siemens Multix Top (Siemens, Munich) ceiling mounted x-244 
ray system in conjunction with a Konica Regius 150 (Konica Minolta, Tokyo) computed 245 
radiography system, using the following exposure parameters: source to image receptor 246 
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distance (SID) 115 cm, fine focus (0.6 mm focal spot), 50 kVp and 1 mAs. The images 247 
were processed using a Konica Regius 150 pre-programmed fixed linear look-up table. 248 
 249 
The assessment of bone mineral density (BMD) was undertaken within the same regions 250 
of interest as identified for the Raman microspectroscopy, namely the anterior, PUQ and 251 
PLQ. A miniature aluminium step-wedge (7 steps, each 0.5 mm in depth) was included 252 
in all projection radiographs undertaken to enable the calculation of the BMD of each 253 
area/sample in terms of mm of aluminium equivalence. Aluminium has an atomic 254 
number of 13, and the effective atomic number of bone has been cited of the order of 255 
11.6 – 13.8 (28). Hence, for the purposes of normalisation, it was assumed that the 256 
relationship between thickness of aluminium and image intensity was comparable to the 257 
relationship between thickness of bone and image intensity. This yielded a dataset 258 
consisting of image intensity values which were then converted into mm of aluminium 259 
equivalence in order to enable meaningful comparison of bone volume to be made. In 260 
order to correct for any variation in the thickness of different bone samples and across 261 
the sample, multiple thickness measurements were taken for each sample using a 262 
micrometer, and the results averaged. The average number of measurements within 263 
each region were: PLQ 6 (range 5 – 9), PUQ 3 (range 2 – 5), Anterior 6 (range 5 – 9). 264 
Each BMD was then corrected such that it represented the BMD per mm of bone as an 265 
aluminium equivalence. 266 
A WSR was subsequently calculated equal to the ratio of the BMD found in the PLQ 267 
region of interest to the average of the BMDs found in the anterior and PUQ regions. 268 
 269 
Data analysis 270 
Statistical analysis was conducted using SPSS version 22.0 (SPSS Armonk, NY). 271 
Results quoted are given as mean ± standard error. To assess the relationship between 272 
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BMOA presence and age, binary logistic regression was run. Given the lack of 273 
demographic information, no other variables were included wtihin the analysis. For 274 
Raman outcome measures testing was undertaking to examine whether WSRs were 275 
different for sample slices with and without BMOA via unpaired t-tests. To assess 276 
whether there was a general tendency for PLQ bone density to be higher than the rest of 277 
the sample, BMD data from all samples were combined, and a 1-sample t-test run to 278 
examine whether WSR values were greater than unity. Subsequently WSR BMD values 279 
were compared for the BMOA and control groups via an unpaired t-test.  280 
 281 
RESULTS 282 
Prevalence of BMOA 283 
BMOA was present in 19 horses out of a total of 43 (44%) from which forelimbs were 284 
utilised. Of those 22 horses which had both forelimbs scanned, only two (9%) had 285 
evidence of BMOA bilaterally in the forelimbs. Of a total of 65 forelimbs scanned, 21 286 
(32%) had evidence of BMOA. From binary logistic regression no significant relationship 287 
between BMOA presence and age was found (B= -0.033, ExpB= 0.967, Wald = 0.228, p 288 
= 0.630).  289 
 290 
Anatomical location of BMOA 291 
The anatomical location of the BMOA was, in the majority of cases (18 out of 21 292 
forelimbs), on the palmar (posterior) surface, approximately 5 – 10 mm proximal to the 293 
transverse ridge and approximately 5 – 15 mm from the sagittal ridge with lesions being 294 
demonstrated both medially and laterally. Three BMOA lesions were found in atypical 295 
locations compared to the majority of lesions. The atypical locations were as follows; the 296 
dorsal surface of the epiphysis, central within the distal diaphysis of the metacarpal and 297 
on the palmar surface but more superior / proximal. These samples were subsequently 298 
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excluded. A number of limbs (4 or approximately 19%) had BMOA lesions on both sides 299 
of the sagittal ridge. Only one BMOA lesion had an associated cartilage lesion that was 300 
demonstrable on the MRI scans. This lesion penetrated the subchondral bone and had 301 
an associated subchondral bone deformity. 302 
 303 
Raman Microspectroscopy 304 
For the subset of samples for which Raman microspectroscopy and projection 305 
radiography were undertaken (BMOA group n = 8, control group n = 17), an average of 306 
66 (range 39 – 166) separate Raman microspectroscopy measurements were taken per 307 
sample, of which an average of 29.5% were in the PLQ. For the WSR values for 308 
phosphate peak centre, the difference between BMOA and control groups (1.0001 ± 309 
8.23x10-5, 0.9999 ± 8.77x10-5, respectively, p = 0.213) was not significant at the p = 0.05 310 
level, i.e., even without a statistical correction for multiple comparisons. 311 
 312 
Similarly, no significant differences were found between the BMOA and control groups 313 
for phosphate:amide I  (1.071 ± 0.037, 1.042 ± 0.084 respectively, p = 0.752), 314 
carbonate:amide I (0.950 ± 0.060, 0.914 ± 0.052 respectively, p = 0.658) or 315 
carbonate:phosphate (0.845 ± 0.086, 0.866 ± 0.075, p = 0.857). 316 
 317 
Projection Radiography  318 
When control and BMOA groups were combined, WSR values significantly greater than 319 
1 were found (1.132 ± 0.039, p = 0.003) suggesting a regional bone density variation, 320 
with greatest bone density in the PLQ region of interest, the region associated with the 321 
greatest loading on the joint. When comparing BMOA and control group WSR, there was 322 
a statistically significant difference between the ratios (1.244 ± 0.029, 1.079 ± 0.052 323 
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respectively, p = 0.011) indicating a higher bone density in the PLQ region associated 324 
with the presence of BMOA.  325 
 326 
DISCUSSION 327 
Of the 65 samples examined approximately a third were found to have BMOA lesions 328 
present. When regions of interest were defined within the samples, no significant 329 
differences in the variation between the regions were found when using Raman 330 
microspectroscopy to compare BMOA and control samples. However, equivalent 331 
comparisons revealed a significant difference when bone mineral density was examined, 332 
suggesting an association between BMOA and underlying bone density changes.  333 
 334 
Location of the BMOA lesions  335 
It is of interest that the majority of the BMOA lesions observed were in a very specific 336 
location, corresponding to the region of greatest loading within the joint and which is 337 
associated with  injury and lameness in racehorses (29, 30). High levels of training 338 
amongst young horses, such as race-horses, have been shown to be associated with 339 
micro-fractures at high-strain sites including the dorsal third metacarpal (30) and it does 340 
appear likely that the apparently characteristic location of the BMOA is related to the 341 
loading upon the joint. This may be linked to traumatic damage in some way, even in the 342 
absence of clear damage to the articular cartilage, although there was no evidence of 343 
microfracture within the samples studied.  344 
 345 
Bone Density 346 
The data yielded by projection radiography show that bone density relative to the rest of 347 
the slice is increased at sites with BMOA in a way that is not observed at  equivalent 348 
sites in samples where BMOA is absent. This mirrors findings within a clinical study of 349 
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268 human subjects where BMOA lesions in the knee at the site of greatest loading 350 
were correlated with increased local bone mineral density (31) and more recent work in 351 
the human tibia that has demonstrated an association between BMOA and thickened 352 
trabeculae that are increased in number and with less spacing (32). Given that changes 353 
in the hydrostatic pressure of bone marrow may affect the stem and progenitor cells 354 
present within bone marrow altering the homeostasis of bone (33) it is possible that 355 
BMOA is associated with altered hydrostatic pressure in bone marrow and that the 356 
changes in bone density observed are a reflection of increased bone deposition . 357 
However, further work is required to examine this hypothesis.  358 
 359 
Bone composition 360 
The Raman microspectroscopy measurements related to a range of bone composition 361 
characteristics, indicating crystallinity, mineral:matrix ratio, and type-B carbonate 362 
substitution. Results showed no significant differences in WSR between samples where 363 
BMOA was present and samples where BMOA was absent. The conclusion is thus that 364 
BMOA is not associated with modification in bone composition.  365 
It has been demonstrated both in-vitro (34) and in vivo (35, 36) that the phosphate band 366 
centre shows a positive shift with bone maturity due to increasing tissue age rather than 367 
animal age (37). That the WSRs for this parameter showed no significant difference 368 
between BMOA samples and controls is thus indicative of there being no difference in 369 
the proportion of immature bone present and thus no difference in the amount of 370 
remodelling taking place at BMOA sites. 371 
 372 
Changes in mineral:matrix ratio with age have previously been observed in humans with 373 
no known bone disorders (33), and may be related to changes in the remodelling rate. 374 
Changes in matrix component with age (indicated by the amide I component) have also 375 
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been observed (23). A study of collagen structure of normal human trabecular iliac bone 376 
using chemical analysis (38) demonstrated a reduction in the amount of collagen with 377 
age. In the present study, no mineral: matrix ratio changes were detected in the BMOA 378 
region compared to the rest of the sample slice, suggesting  that BMOA is not 379 
associated with either altered mineral or matrix composition. 380 
 381 
Previous Raman studies of bone have principally focused on cortical bone, both animal 382 
and human (22, 23, 34, 39), which has a well-defined structure of osteons joined by 383 
interstitial lamellae, whereas the current study encompassed trabecular bone. It has 384 
been suggested that the average mineral content and crystallinity of homogenised 385 
cortical bone does not vary with age, even though individual components do exhibit age-386 
related changes (39) because age-related changes in the primary lamellar bone which is 387 
formed in the latter stages of puberty and remains present throughout the lifespan of an 388 
individual, may be negated by the remodelling that occurs in the secondary osteons (39) 389 
in terms of measurement of overall composition. Trabecular bone does not have a 390 
component that is equivalent to primary lamellar bone, it undergoes constant 391 
remodelling and therefore has a high degree of variability in terms of chemical 392 
composition which may provide an explanation for the present inconclusive results.  393 
 394 
Limitations 395 
The study represents only a small-scale assessment of the use of horse-bone sources to 396 
examine BMOA. In addition, the sample population used for these studies was 397 
heterogeneous, with very limited demographic information. Hence it was not possible to 398 
consider the effect on the measured data of horse breed, sex or working history. It was 399 
possible to consider the effect of horse age (see above), but these data require cautious 400 
interpretation as ageing a horse using dental examination is not precise (18),. 401 
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Furthermore, the study did not attempt to evaluate or grade the tissue samples for 402 
osteoarthritis. However, despite these limitations, the study provides evidence that 403 
differences in bone density are associated with BMOA, suggesting that the techniques of 404 
the present study may provide useful avenues for further exploration. 405 
 406 
Future work 407 
Intra-vital studies have previously demonstrated that fracture healing in bone can also be 408 
assessed with Raman microspectroscopy by measuring the lipid and phospholipid 409 
present in cell membranes that are a marker of cell death, although quantifying the 410 
presence of blood products is more difficult due to structural modifications associated 411 
with exposure to the laser (22). As a supplement to the current study, such techniques 412 
could be used to examine whether BMOA lesions are associated with micro-damage. 413 
However, this would require the development of better methods for sample handling – in 414 
the present study, the bone marrow could not be preserved due to the method of sample 415 
preparation and storage (under saline) and blood breakdown in the time between 416 
euthanasia and Raman data collection would have resulted in spectrum modification.  417 
 418 
Combining Raman microspectroscopy in a controlled equine population, alongside 419 
techniques such as histology or Scanning Electron Microscopy would enable information 420 
about bone remodelling to be correlated with any demonstration of micro-fracture, cracks 421 
and histological evidence of bone remodelling. Whilst there are differences between 422 
equine and human bone it is also felt that there are similarities, for example in the 423 
pathogenesis of osteochondrosis (40) that may also render these findings applicable to 424 
the human population. 425 
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CONCLUSION 426 
The majority of the BMOA lesions observed in the equine metacarpophalangeal joint 427 
occurred at a characteristic location corresponding to the region of greatest loading 428 
within the joint, in a region associated with palmar osteochondral disease (29, 30). The 429 
data presented here demonstrated an association between BMOA and locally increased 430 
bone density, without an associated change in the chemical composition of bone. The 431 
presence of increased bone density associated with BMOA does appear to suggest that 432 
an increased amount of bone formation is occurring in these regions. As the Raman 433 
microspectroscopy data do not demonstrate any significant changes in bone chemical 434 
composition associated with BMOA, it would appear that the increased bone volume is 435 
due to a greater amount of bone being formed rather than an imbalance in relation to 436 
bone remodelling. The study provides a proof of principle for the use of Raman 437 
microspectroscopy and projection radiography in in-vitro studies of BMOA. These 438 
techniques may be a useful adjunct for further investigations into the pathophysiology of 439 
equine joint disease, which may have some relevance to similar conditions in the human 440 
population. 441 
  442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
 450 
 451 
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LIST OF ABBREVIATIONS 452 
 453 
BMOA  bone marrow oedema-like abnormalities 454 
MRI  magnetic resonance imaging 455 
STIR  short tau inversion recovery 456 
w/v  weight by volume 457 
PUQ  posterior upper quadrant 458 
PLQ  posterior lower quadrant 459 
WSR  within slice ratio 460 
SID  source to image receptor distance 461 
BMD  bone mineral density 462 
 463 
 464 
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 637 
 638 
Figure Titles and Legends 639 
Figure 1 Title: 640 
Dorso-palmar (antero-posterior) radiograph of the metacarpophalangeal joint.  641 
Figure 1 Legend: Key: a) third metacarpal bone, b) proximal phalanx, c) proximal 642 
sesamoid bones, d) metacarpophalangeal joint.  643 
 644 
Figure 2 Title: 645 
Parasagittal magnetic resonance images of the metacarpophalangeal joint. 646 
Figure 2 Legend; T1w image on left, STIR image on right, no evidence of BMOA 647 
 648 
Figure 3 Title: 649 
Coronal and midline sagittal magnetic resonance images of the metacapophalangeal 650 
joint. 651 
Figure 3 Legend: Arrows indicate the region of the BMOA 652 
Figure 4 Title: Mid-sagittal magnetic resonance images of the metacarpophalangeal 653 
joint. 654 
Figure 4 Legend: Arrows indicate the region of the BMOA. 655 
 656 
Figure 5 Title: 657 
Photographs of parasagittal (medial) bone section  658 
Figure 5 Legend: (a) represents sampling pattern for locations of individual Raman 659 
microspectroscopy measurements (indicative only) and, (b) regions of interest used for 660 
Raman microspectroscopy and bone density measurements.  661 
 662 
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Figure 6 Title: 663 
Expanded portion of Raman spectrum demonstrating position of peaks of interest. 664 
